|
GDE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.94270000000763E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.004790E-04 |
| Normal-vs-Stage2 |
3.602200E-03 |
| Normal-vs-Stage3 |
8.800000E-03 |
| Normal-vs-Stage4 |
1.755620E-02 |
| Stage1-vs-Stage2 |
7.548800E-01 |
| Stage1-vs-Stage3 |
3.563800E-01 |
| Stage1-vs-Stage4 |
6.107600E-01 |
| Stage2-vs-Stage3 |
3.312000E-01 |
| Stage2-vs-Stage4 |
4.842000E-01 |
| Stage3-vs-Stage4 |
8.530600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.398000E-04 |
| Normal-vs-AfricanAmerican |
2.294500E-02 |
| Normal-vs-Asian |
6.322700E-03 |
| Caucasian-vs-AfricanAmerican |
9.793600E-01 |
| Caucasian-vs-Asian |
8.299200E-01 |
| AfricanAmerican-vs-Asian |
8.982600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.380700E-04 |
| Normal-vs-Female |
2.359400E-04 |
| Male-vs-Female |
5.407000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.08490000000095E-05 |
| Normal-vs-Age(41-60Yrs) |
3.515300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.360000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.368800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.568000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.577400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.011400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.131800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.542800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.945600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.965000E-01 |
| Classical-VS-Follicular |
1.692180E-02 |
| Classical-VS-Other |
1.419370E-01 |
| Classical-VS-Normal |
3.34759999998102E-06 |
| Tall-VS-Follicular |
7.508500E-02 |
| Tall-VS-Other |
9.012300E-02 |
| Tall-VS-Normal |
9.425100E-04 |
| Follicular-VS-Other |
5.747600E-01 |
| Follicular-VS-Normal |
1.295970E-01 |
| Other-VS-Normal |
9.958000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.921700E-03 |
| Normal-vs-N1 |
1.542560E-01 |
| N0-vs-N1 |
5.127000E-01 |
|
|
